Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Drugs administration

Phase 1Small molecule

HHebei Medical University Third Hospital

1

Indications

2

Total Trials

2

Active Trials

0

Competitors

Timeline

Expected Milestones

Q4 2026

Phase 1Active, not recruiting

Injury

NCT07192302

Clinical

Trials by Indication[1]

Injury1 trial

Partial Rotator Cuff Injury Combined With Stiff Shoulder

Active, not recruiting·HHebei Medical University Third Hospital·Phase 1·NCT07192302·80 enrolled

Trauma1 trial

Prehospital Management of Hypotensive Trauma in HEMS

Recruiting·AAzienda Usl di Bologna··NCT04760977·500 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Drugs administration. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Drugs administration compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Drugs administration. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Hebei Medical University Third Hospital company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 1[1]
Company: HHebei Medical University Third Hospital

Related News